A CRISPR/Cas9-based central processing unit to program complex logic computation in human cells.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 04 2019
Historique:
pubmed: 30 3 2019
medline: 23 5 2019
entrez: 30 3 2019
Statut: ppublish

Résumé

Controlling gene expression with sophisticated logic gates has been and remains one of the central aims of synthetic biology. However, conventional implementations of biocomputers use central processing units (CPUs) assembled from multiple protein-based gene switches, limiting the programming flexibility and complexity that can be achieved within single cells. Here, we introduce a CRISPR/Cas9-based core processor that enables different sets of user-defined guide RNA inputs to program a single transcriptional regulator (dCas9-KRAB) to perform a wide range of bitwise computations, from simple Boolean logic gates to arithmetic operations such as the half adder. Furthermore, we built a dual-core CPU combining two orthogonal core processors in a single cell. In principle, human cells integrating multiple orthogonal CRISPR/Cas9-based core processors could offer enormous computational capacity.

Identifiants

pubmed: 30923122
pii: 1821740116
doi: 10.1073/pnas.1821740116
pmc: PMC6462112
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7214-7219

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nat Methods. 2015 Jul;12(7):664-70
pubmed: 26030444
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Nat Methods. 2015 Nov;12(11):1051-4
pubmed: 26344044
Mol Cell. 2014 May 22;54(4):698-710
pubmed: 24837679
Nat Chem Biol. 2014 Mar;10(3):203-8
pubmed: 24413461
Nat Methods. 2014 Jul;11(7):723-6
pubmed: 24797424
Cold Spring Harb Perspect Biol. 2016 Jul 01;8(7):
pubmed: 27194045
Nat Biotechnol. 2017 May;35(5):453-462
pubmed: 28346402
Nat Chem Biol. 2015 Mar;11(3):207-213
pubmed: 25643171
Cell. 2013 Jul 18;154(2):442-51
pubmed: 23849981
Nat Commun. 2017 May 25;8:15459
pubmed: 28541304
ACS Synth Biol. 2016 Jan 15;5(1):81-8
pubmed: 26390083
Nat Methods. 2013 Nov;10(11):1116-21
pubmed: 24076762
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3570-5
pubmed: 25733849
Cell. 2015 Jan 15;160(1-2):339-50
pubmed: 25533786
Biotechnol J. 2015 Jul;10(7):1005-18
pubmed: 26010998
Wiley Interdiscip Rev Syst Biol Med. 2016 Sep;8(5):402-22
pubmed: 27341681
Nat Commun. 2014 Nov 06;5:5393
pubmed: 25373919
Science. 2013 May 3;340(6132):599-603
pubmed: 23539178
Nat Methods. 2016 Dec;13(12):1043-1049
pubmed: 27776111
Nature. 2012 Jul 5;487(7405):123-7
pubmed: 22722847

Auteurs

Hyojin Kim (H)

Department of Biosystems Science and Engineering, ETH Zürich, CH-4058 Basel, Switzerland.

Daniel Bojar (D)

Department of Biosystems Science and Engineering, ETH Zürich, CH-4058 Basel, Switzerland.

Martin Fussenegger (M)

Department of Biosystems Science and Engineering, ETH Zürich, CH-4058 Basel, Switzerland; martin.fussenegger@bsse.ethz.ch.
Faculty of Science, University of Basel, CH-4058 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH